Cardiovascular risk assessment and association with novel biomarkers in patients with Type 2 diabetes mellitus.

To investigate the association between cardiovascular risk and biomarkers in patients with Type 2 diabetes (T2DM). Cross-sectional study, with evaluation of traditional and new biomarkers (serum FGF-23, Syndecan-1 [Sdc-1] and vascular cell adhesion molecule-1 [VCAM-1] and urinary VEGF and kidney injury molecule-1 [KIM-1]) and risk scores (Framingham-FRS and UK Prospective Diabetes Study [UKPDS]). 128 diabetics were included, with predominance of high risk by FRS and low risk by UKPDS.